Where does Agena Bioscience, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Agena Bioscience, Inc. ranks #11,900 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Agena Bioscience, Inc. hold?

Agena Bioscience, Inc. holds 25 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Agena Bioscience, Inc.'s Innovation Score?

Agena Bioscience, Inc. has an Innovation Score of 37.1 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Agena Bioscience, Inc.'s patent grant rate increasing or decreasing?

Agena Bioscience, Inc.'s recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Agena Bioscience, Inc.'s patents?

Agena Bioscience, Inc.'s patents average 20.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Agena Bioscience, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Agena Bioscience, Inc.

Q: What technology areas does Agena Bioscience, Inc. focus on?

Agena Bioscience, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 20 patents, ranking #236 of 2,502 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Agena ranks #11,900 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 9 technology areas.

#11,900
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.1/100): 20.5
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11900 · US Corporation #11,900 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #11,900/49,997
PHOTO-FINISH 360 Electrical L L C
CPC-NARROW C12Q · 9 areas
INNOV-THIN 37.1/100
CLAIMS-DENSE 20.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 360 Electrical, L.L.C. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Agena’s 37.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (30%) Velocity 3.0 pts (8%) Breadth 10.6 pts (28%) Claim depth 12.3 pts (33%)

Qualcomm Incorporated · highest

85
Qingdao Haier Smart… · near

37
Agena Bioscience · this assignee

37
Aker Biomarine… · near

37
Mitsubishi Heavy… · near

37
Salix Pharmaceuticals · near

37
3D Lighting… · lowest

7

What this shows Agena's Innovation Score is 37.1/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Agena?

Each dot is one of Agena’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Agena’s own 20.5 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Agena vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Agena's grants concentrate

Agena Bioscience, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 80% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2017. By volume, Agena sits between Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory and Alexza Pharmaceuticals, Inc..

Agena's three-year grant acceleration

Agena Bioscience, Inc. shows 4 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Zhejiang Medicine…

26
360 Electrical L…

25
Aalyria

25
Adisseo France S

25
Airspan Networks

25
Alcon Lensx

25
Alere SAN Diego

25
Alexza Pharmaceut…

25
Agena Bioscience ◀

25

What this shows Agena holds 25 patents at rank #11,894, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Agena

By rank, the assignees closest to #11,894 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Agena's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Agena, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Agena ranks #236 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Aker Biomarine Antarctic AS 37 Salix Pharmaceuticals, Inc. 37 Mitsubishi Heavy Industries Machine Tool Co., Ltd. 37 Qingdao Haier Smart Technology R&D Co., Ltd. 37

Agena's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Agena Bioscience, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	16.0%
2016	4	16.0%
2017	1	4.0%
2018	2	8.0%
2019	4	16.0%
2020	4	16.0%
2021	1	4.0%
2023	3	12.0%
2024	1	4.0%
2025partial year	1	4.0%

Which technologies does Agena Bioscience, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 20

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 9

Y10T - Technical Subjects Covered BY Former US Classification 6

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 3

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

H01J - Electric Discharge Tubes OR Discharge Lamps 2

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Agena Bioscience, Inc.'s patent record in context - here's where to go next.

Agena Bioscience, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 80% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #11,900 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Agena Bioscience, Inc. against Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.